|
AP1336b-ev
|
Abcepta, Inc.
|
TXNL1 [TRP32/TrxL] [C-term] [RB5394], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP1336b
|
Abcepta, Inc.
|
TXNL1 [TRP32/TrxL] [C-term] [RB5394], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
HY-13784-10mg
|
MedChemexpress LLC
|
Pirodavir [CAS 124436-59-5]
|
|
COVID-19-anti-virus
|
|
|
HY-13784-5mg
|
MedChemexpress LLC
|
Pirodavir [CAS 124436-59-5]
|
|
COVID-19-anti-virus
|
|
|
HY-13784-50mg
|
MedChemexpress LLC
|
Pirodavir [CAS 124436-59-5]
|
|
COVID-19-anti-virus
|
|
|
HY-13784-1mL
|
MedChemexpress LLC
|
Pirodavir [CAS 124436-59-5] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-51424-10mg
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-51424-5mg
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-51424-50mg
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-51424-1mL
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-151462-10mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-151462-100mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-151462-25mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-151462-5mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-151462-50mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-151462-1mL
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P2093B-5mg
|
MedChemexpress LLC
|
S961 (acetate)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P2093A-1mg
|
MedChemexpress LLC
|
S961 (TFA)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P2093A-10mg
|
MedChemexpress LLC
|
S961 (TFA)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P2093A-5mg
|
MedChemexpress LLC
|
S961 (TFA)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-119402-10mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-100mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-25mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-5mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-50mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
